Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ironwood Pharmaceuticals Inc shares valued at $21,869 were sold by Davis Andrew on Nov 18 ’24. At $4.08 per share, Davis Andrew sold 5,360 shares. The insider’s holdings dropped to 284,685 shares worth approximately $1.0 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Emany Sravan Kumar sold 11,001 shares, netting a total of over 44,884 in proceeds. Following the sale of shares at $4.08 each, the insider now holds 309,572 shares.
Before that, Davis Andrew had added 6,090 shares to its account. In a trade valued at $25,030, the Officer bought Ironwood Pharmaceuticals Inc shares for $4.11 each.
As published in their initiating research note from Leerink Partners on September 09, 2024, Ironwood Pharmaceuticals Inc [IRWD] has been a Market perform and the price target has been revised to $5. Analysts at CapitalOne downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in early August. As of January 17, 2024, Craig Hallum has initiated its “Buy” rating for IRWD. Earlier on December 14, 2023, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for IRWD stock.
Analyzing IRWD Stock Performance
During the last five days, there has been a drop of approximately -18.23%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -69.23%. Shares of the company reached a 52-week high of $15.70 on 02/14/24 and a 52-week low of $3.51 on 11/20/24. A 50-day SMA is recorded $4.25, while a 200-day SMA reached $6.79. Nevertheless, trading volume fell to 1.61 million shares from 1.52 million shares the previous day.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
According to the 24-hour chart, there is a support level at 3.42, which, if violated, would cause prices to drop to 3.32. In the upper region, resistance lies at 3.71. The next price resistance is at 3.90. RSI (Relative Strength Index) is 35.53 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.55, which suggests the price will decrease in the coming days. Percent R is at 99.04%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
